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One of the effector arms of the pathogenesis of severe forms of malaria disease is
the development of uncontrolled or excessive inﬂammatory responses. A characteristic
inﬂammatory response may arise from the propensity of some individuals to produce IgE
antibodies against environmental antigens or against parasite components.We believe that
an allergic inﬂammatory response which develops concomitantly with a malaria episode
may drive the disease course toward severe forms. The role of the IgE–FcεRI complex
in malaria severity in Plasmodium falciparum-hosting patients is unknown. Subsequently,
except a very limited number of reports, study of effector cells that express this complex
such as mast cells and basophils and that may contribute to malaria pathogenesis have
been particularly neglected. A better understanding of this type of inﬂammatory response
and its implication in malaria disease and how it impacts Plasmodium parasite development
may provide additional tools to alleviate or to cure this deadly disease.
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INTRODUCTION
Natural immunity to malaria is usually acquired slowly and its
maintenance requires repeated parasite exposures (Greenwood,
1999). This immunity reduces the risk of both severe and mild
malaria but does not diminish parasitemia. The defense mecha-
nisms require cooperation between antibodies (Ab) and cellular
immune responses (Bouharoun-Tayoun et al., 1995). Antibody-
dependent mechanisms have been clearly shown to play an impor-
tant role in the anti-parasite immunity and can reduce clinical
symptoms in humans, as demonstrated by the positive effect of
hyperimmune immunoglobulin G (IgG) passively transferred to
infected patients (Bouharoun-Tayoun et al., 1990; Plebanski and
Hill, 2000). IgE levels and IgE anti-plasmodial Ab are elevated
in human and experimental malaria infections, but their role
in protection and/or pathogenesis in malaria is still controver-
sial (Desowitz, 1989; Perlmann et al., 1994; Troye-Blomberg et al.,
1999). According to these authors, adults, and children living in
malaria-endemic areas in different African and Asian countries
including Liberia, The Gambia,Madagascar, and Thailand 85% of
the donors had signiﬁcantly elevated levels of IgE and more than
60% of these had detectable antimalarial speciﬁc IgE antibodies
as compared to healthy and atopic SWEDISH donors (Perlmann
et al., 1994).
The most important and widely investigated biological func-
tions of IgE are anti-parasite immunity, especially against nema-
todes, and IgE-mediated allergic responses. It is believed that
uncontrolled inﬂammatory responses are a characteristic fea-
ture of the pathogenetic mechanisms of severe forms of malaria.
We became interested in exploring the role of IgE-mediated
inﬂammatory response in malaria disease such as cerebral malaria
(CM). In the present review, we will discuss data from several
immuno-epidemiological human studies in various geographical
areas as well as data from experimental studies using a murine
model of CM.
ROLE OF IgE IN MALARIA INFECTION AND DISEASE
Assessment of the antibody response against Plasmodium falci-
parum blood stages determined in individuals naturally exposed
to malaria in endemic areas of Brazil shows that the highest levels
of IgG1, IgG2, and IgG3 antibodies were observed in individu-
als with asymptomatic and uncomplicated malaria, while highest
levels of IgG4, IgE, and IgM antibodies were predominant among
individuals with complicated malaria (Leoratti et al., 2008). These
results are in agreement with those of other investigators who
demonstrated that Plasmodium-speciﬁc IgG1 and IgG3 antibod-
ies have a protective role against malaria, while lgG4 antibodies
very likely do not protect against the disease (Sarthou et al., 1997;
Taylor et al., 1998; Tangteerawatana et al., 2001, 2007).A consistent
observation, however, indicate that high overall levels of IgE have
been found in populations exposed to malaria (Perlmann et al.,
1994) in 94% of the individuals studied. However, there is some
controversy as to the role of speciﬁc IgE antibodies and whether
they serve to protect against the disease or to make the illness more
severe.
Several ﬁndings suggest that IgE could play a detrimental
role during malaria disease development. This was supported by
data showing that IgE levels were reduced amongst patients with
uncomplicated malaria in comparison to those suffering from
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severe malaria (Perlmann et al., 1994, 1997, 2000; Seka-Seka et al.,
2004). Furthermore, immunohistological studies onbrain sections
revealed the presence of IgE deposits in brain microvessels and on
infected erythrocytes from CM patients as well as in placentas
infected with P. falciparum (Maeno et al., 1993, 2000). Various
immune complexes (ICs), which consist of either IgE and antigen
aggregates or IgE with IgG anti-IgE, could bind to Fc receptors
expressed on monocytes which become activated giving rise to
TNF-α secretion (Elghazali et al., 1997; Perlmann et al., 1999).
Although TNF-α may play a protective role against the parasites,
elevated levels in the bloodwere related toworsening of the disease
and death in cases of severemalaria (Grau et al., 1989;Kwiatkowski
et al., 1990). In addition, IgE levels were found to be higher in
cerebral P. falciparum malaria when compared to uncomplicated
malaria (Desowitz, 1989; Luty et al., 1994). Among patients with
severemalaria, the increase in IgE levels was related to the deepness
of the coma (Maeno et al., 2000).
In the opposite, other evidence could support the notion that
speciﬁc IgE antibodies provide protection against malaria: (a)
IgE levels increase with age which determines the acquisition of
immunity (Desowitz et al., 1993;Maeno et al., 1993); (b) high con-
centration of IgE antibodies against P. falciparum were lower in the
comatose patients than in the non-comatose patients (Calissano
et al., 2003); (c) A study carried out in the ethnic group Fulani,
known to be less susceptible tomalaria infections, revealed that the
Fulani were less parasitized, had fewer circulating parasite clones
in their blood, and had signiﬁcantly higher anti-malaria IgG and
IgE antibodies as well as higher proportions of malaria-speciﬁc IL-
4- and IFN-γ-producing cells compared to the more susceptible
Dogon individuals (Farouk et al., 2005); (d) a study in Tanza-
nia has shown that elevated levels of malaria-speciﬁc IgE reduces
the risk of subsequent malaria attacks (Bereczky et al., 2004); (e)
More recently, antigen-speciﬁc IgE antibodies in asymptomatic
and uncomplicated malaria patients were found to be higher than
in severe or CM groups (Duarte et al., 2007).
Among the reasons that account for these apparently antag-
onistic roles of IgE in malaria disease are, of course, the genetic
diversity of human populations involved in the different stud-
ies, but also and more importantly the concomitant infections,
diseases, or even silent carriage of microorganisms. As will be dis-
cussed below, in addition to a number of polymorphisms in host
genes, one single infected individual may harbor a diversity of
genetically different Plasmodium parasites, hence increasing the
number of variables that need to be controlled for a better appre-
ciation on whether and how IgE response determines the outcome
of malaria disease.
Antibodies of various isotypes can exert their effector function
as soluble monomeric form or as ICs bound either to antigens or
to autoantibodies. Children with severe malaria-associated ane-
mia and CM had signiﬁcantly higher IC levels than their respective
controls suggesting a possible role for ICs in the pathogenesis of
CM (Adam et al., 1981;Mibei et al., 2005). However, albeit ICsmay
be involved in the pathogenesis of these two clinical presentations,
they alone cannot explain their distinct clinical manifestations.
Moreover, children developing CM may be more susceptible to
IC-mediated inﬂammatory response occurring in the brain or
there may be qualitative rather than quantitative differences in ICs
between these groups that could further impact on the clinical pre-
sentation. In a study performed in Kenya, levels of IgE-containing
ICs were higher in children with CM than in their controls and
were the only independent predictors of CM at enrollment (Mibei
et al., 2008). In support of the role of ICs in the pathogenesis of
CM, IgE deposits found in the brain obtained from CM fatali-
ties may induce TNF-α (Clark and Cowden, 1992) from activated
monocytes (Perlmann et al., 1999) or alternatively, induce medi-
ator release such as histamine from stimulated basophils or mast
cells.
Several evidences indicate that basophils might represent effec-
tor cells by regulating the Th1/Th2 balance, which may affect the
outcome of malaria disease. Evidence has been provided support-
ing the role of basophils in the polarizing capacity toward Th2 cells
in the murine Plasmodium chabaudi chabaudi system. Here, it has
been shown that a population of IL-3 responsive IL-4 producing
non-B non-T (NBNT) cells of basophil origin expand in the spleen
and in the peripheral blood during acute infection (Poorafshar
et al., 2000). Other evidences show that IgE antibodies that form
ICs were potent inducers of IL-4 in human basophils, potentially
regulating the switch fromTh1 toTh2 cells (Nyakeriga et al., 2003).
However, no functional relationship between increased number of
basophils and their potential activation by IgE ICs and the disease
severity could be formally established.Very recently, we found that
in a murine model of CM, speciﬁc depletion of basophils using
the Ba103 antibody did not result in any change of the phenotype
of the C57BL/6 mice regarding the development of CM (Porcherie
et al., 2011).
GENETIC LINKAGE STUDIES: CONTROL OF MALARIA
DISEASE BY ALLERGIC RESPONSE-ASSOCIATED GENES
A REGION OF THE CHROMOSOME 5q31 IS ASSOCIATED WITH MALARIA
SUSCEPTIBILITY
Genome wide association studies (GWAS), which allows the iden-
tiﬁcation of genetic factors underlying phenotypic traits, revealed
several genes involved in infection and/or malaria disease severity.
Thus, a number of studies have provided evidence that a genome
region, 5q31–33, that contains a cluster of genes encoding cytokine
and growth factors was found to be signiﬁcantly linked to malaria
parasite density (Rihet et al., 1998), and involved in the control
of immunity to P. falciparum blood stage (Troye-Blomberg et al.,
1994). In another longitudinal survey carried out independently
for Dielmo and Ndiop, two Senegalese villages that differ in para-
site transmission and endemicity, parasite density showed linkage
to a region on chromosome 5q31 (Sakuntabhai et al., 2008) previ-
ously identiﬁed to overlap with those that have been shown to be
linked to asthma/atopy related traits and to elevated IgE levels.
The importance of this region in immune regulation is high-
lighted by its linkage to plasma IgE levels (Marsh et al., 1994;
Meyers et al., 1994), bronchial hyperresponsiveness (Postma et al.,
1995), and to Schistosoma mansoni infection intensity (Marquet
et al., 1996) in humans and with resistance to P. chabaudi in
mice (Hernandez-Valladares et al., 2004). Several genes encod-
ing mostly TH2 cytokines, IL-13, IL-4, IL-5, IL-9, IL-3, but also
the Th1 cytokine IL-12B, are clustered in the 5q31–33 region and
may represent strong candidates for controlling the outcome of
infection or malaria disease. It is therefore interesting to explore
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genes in the 5q31 region for identifying variants associated with
susceptibility or resistance to severe malaria.
ASSOCIATION OF Th2 CYTOKINE GENE POLYMORPHISMS WITH
SEVERE MALARIA
IL-4 polymorphism
The gene for IL-4, a pleiotropic cytokine promoting antibody IgE
isotype switching, lies altogether with other Th2 cytokine genes
in the 5q31 region previously shown to be linked to P. falciparum
infection (Rihet et al., 1998). A study in Burkina Faso has shown
that an allelic variant – 589T in the promoter region of IL-4 is
associated in the Fulani with higher levels of antibodies to several
P. falciparum antigens (Luoni et al., 2001). The proportions of P.
falciparum-induced IL-4, IFN-γ, IL-10, and IL-12 producing cells,
were compared between Fulani and Dogon from Mali. Both IFN-
γ (Th1) and IL-4 (Th2) producing cells were present in higher
numbers in Fulani than in Dogon, which suggests that the Fulani
resistance to malaria is not mediated by a Th2 polarized immune
response, it could be more likely the result of a generally stronger
immune activation or weaker immune suppression.
Further investigations were carried out in the attempt to cor-
relate this IL-4 allelic variant with disease severity within a case–
control study in Burkina Faso (Verra et al., 2004), and another
case–control study in Ghana (Gyan et al., 2004). The former study
showed no difference in allele frequency between severe malaria
cases and uncomplicated malaria patients; however, within severe
malaria cases higher total IgE levelswere observed inbothhomozy-
gous and heterozygous IL-4-589T carriers. Moreover, the latter
study revealed higher total IgE levels in CM cases carrying the
IL-4-589T allelic variant.
IL-13 polymorphism
The switch recombination of immunoglobulins to the IgE isotype
requires two signals from activated T cells: the up-regulation of
the CD40 ligand and the secretion of IL-4 or IL-13. Both IL-4 and
IL-13, independently of each other, are able to induce IgE antibody
production (Punnonen et al., 1993). Inductionof CD23 expression
on B cells is another shared activity between IL-4 and IL-13 (Pun-
nonen et al., 1993). An initial study performed in patients that live
in Northwest Thailand has demonstrated that a single nucleotide
polymorphism (SNP) in the IL-13 promoter region was found to
be associated with susceptibility to severe malaria (Ohashi et al.,
2003). In amore recent study, this SNPwas found to be included in
a haplotype block on chromosome 5q31 encompassing the whole
RAD50 gene and the promoter of the IL-13 gene (Naka et al.,
2009). RAD50 itself, which is part of a multiprotein complex that
is involved in B cell-speciﬁc immunoglobulin gene diversiﬁcation
(Yabuki et al., 2005), may inﬂuence afﬁnity or effector functions
of antibodies. More recently, polymorphisms within the RAD50
gene were consistently associated with IgE levels and increased the
risk for atopic eczema and asthma (Weidinger et al., 2008).
OTHER GENES
CD154 polymorphism
CD40 ligand (CD40L), a glycoprotein involved in B cell prolifer-
ation, antigen presenting cell activation, and Ig isotype switching
plays a pivotal role in the immune response to infection. Besides
signals provided by IL-4, engagement of CD40 expressed by B cells
by the CD40 ligand (CD40L) expressed on activated T cells leads
to switching to IgE isotype during immunoglobulin synthesis in B
cells. To identify CD40L polymorphisms associated with malaria
severity, Gambian males that are hemizygous for CD40L-726C
exhibit signiﬁcant protection against CM and severe malarial ane-
mia (Sabeti et al., 2002). A polymorphism in the promoter region,
CD40L-726T/C, was tested for association with malaria in a case–
control study in The Gambia revealing a signiﬁcant association of
the CD40L-726C allele with severe malaria, both severe anemia
and CM, in hemizygous (X-linked trait) males.
Haptoglobin
A hemoglobin binding protein, is another candidate gene for
which the polymorphism pattern has been explored to estab-
lish an association between past malaria morbidity and atopic
diseases. Amongst the malaria patients, the haptoglobin Hp1/1
phenotype was signiﬁcantly more prevalent for patients showing
the complications of CM and severe anemia compared to patients
with uncomplicated disease (Quaye et al., 2000). A study con-
ducted in atopic children living in Sardinia showed that the Hp1/1
genotype which was expressed at higher frequency in populations
subjected to high malarial endemia also showed a higher incidence
in patients with atopic diseases than in control population (Bot-
tini et al., 1999). Hp 1/1 was shown to be overrepresented in atopic
asthma (Bottini et al., 1999) but also in allergic contact dermatitis
and allergic rhinitis (Langlois and Delanghe, 1996).
Neutrophil-associated genes
The role of neutrophil activation in the host response to P. fal-
ciparum remains under-investigated. Host resistance to malarial
infection is not classically attributed to a neutrophil response
(Stevenson andRiley, 2004). However, examining gene-expression
proﬁles in whole blood from Kenyan children, Grifﬁths et al.
(2005) identiﬁed a cluster associated with neutrophil activity,
including absolute neutrophil count and neutrophil-related gene-
expression. A signiﬁcant increase in gene-expression intensity
corresponded to a signiﬁcant increase in neutrophil count in sub-
jects who had acute malaria as compared to convalescent subjects.
Indeed, it has been observed that neutrophilia has been linkedwith
acute malaria (Ladhani et al., 2002). However, the effector mech-
anisms by which neutrophils contribute to malaria pathogenesis
remain to be explored.
EFFECTOR MECHANISMS OF ALLERGIC RESPONSE
INVOLVED IN MALARIA PATHOGENESIS
In humans, studies aiming at establishing the allergic nature of
malaria disease report conﬂicting results ranging from disease-
aggravating to disease-protecting roles of IgE (Perlmann et al.,
1997; Bereczky et al., 2004). To clarify this issue,we used genetically
deﬁcient animals or antibody-depleted cell populations to exam-
ine crucial components of the allergic inﬂammatory response in
malaria pathogenesis. To this aim, we used a murine model of CM
which relies on the infection of a susceptibleC57BL/6mouse strain
with the PbANKA parasite strain. Neurological signs followed by
death occur between 6 and 11 days post-infection.
www.frontiersin.org December 2011 | Volume 2 | Article 78 | 3
Blank and Mécheri Allergic inﬂammatory response and malaria
ROLE OF HISTAMINE AND HISTAMINE RECEPTORS IN MALARIA
PATHOGENESIS
We previously reported that Anopheles stephensi mosquito bites
result in a local IgE-independent degranulation of skin mast
cells as assessed by a rapid dermal inﬂammation and the hyper-
plasia of the draining lymph nodes (Demeure et al., 2005).
This provided a mechanism whereby mosquito bites may shape
the immune response to sporozoites present in their saliva and
inoculated during the blood meal. The sites of mosquito bites
are characterized by ﬂuid extravasation and rapid inﬁltration
with polynuclear neutrophils. This rapid onset of inﬂamm-
atory responses led us to hypothesize that histamine release
may represent one of the mechanisms that facilitates parasite
transmission during inoculation by infected Anopheles mosqui-
toes. Indeed, increased levels of histamine in plasma and tis-
sue, were found to be associated with the severity of disease
in humans infected with P. falciparum and in several animal
models of infections with Plasmodium (Maegraith and Fletcher,
1972; Srichaikul et al., 1976; Bhattacharya et al., 1988). The
increase in vascular permeability appears to be a component of
malaria pathogenesis and could be advantageous for the para-
sites, as sporozoites or blood stage parasites, since it facilitates
their entry and exit from blood vessels. The vasodilatory effects
of histamine might promote spread of the parasite through the
vasculature.
Based on divergent approaches using H1R−/− and H2R−/−
mice, anti-histamine drugs, and histamine-deﬁcient mice, we
demonstrated that histamine signaling was associated with the
severity of disease (Beghdadi et al., 2008). Mice genetically
deﬁcient in H1R and H2R as well as mice treated with H1
and H2 anti-histamines revealed a delayed mortality as com-
pared to similarly infected wild-type mice that had not been
treated with anti-histamines. This suggests that production
and binding of histamine to these two receptors are delete-
rious to the host (Beghdadi et al., 2008). Unequivocal impli-
cation of histamine in malaria pathogenesis was provided by
the use of histidine decarboxylase-knock out (HDC−/−) mice
which did not develop neuropathology in contrast to wild-
type mice (Beghdadi et al., 2008). Histamine production can
be elicited from circulating basophils either via cross-linking of
parasite-speciﬁc IgE antibodies or by the translationally con-
trolled tumor protein (TCTP), a parasite-derived homolog of
the histamine releasing factor (HRF). TCTP has been found
in the plasma of patients infected with P. falciparum and was
shown to trigger histamine release from basophils and IL-
8 secretion from eosinophils (MacDonald et al., 2001). The
existence of a Plasmodium protein that stimulates histamine
release lends support to the hypothesis that histamine signal-
ing is advantageous to the parasite, and thus harmful to the
host. These ﬁndings could provide a rational basis for higher
levels of histamine in blood and in tissues during malaria
as a result of the activity of vector- or parasite-derived con-
stituents. Amplifying the host inﬂammatory response, via hist-
amine signaling, may be a strategy developed by the parasites
to create conditions advantageous for their own survival and
persistence.
IMPLICATION OF NEUTROPHILS EXPRESSING UNCONVENTIONAL FcεRI
IN ELICITING SEVERE MALARIA
We found that targeted disruption of IgE or the α chain of FcεRI
led to resistance to the development of ECM after infection with
PbANKA(Porcherie et al., 2011). These results indicate a patholog-
ical role of IgE that acts via FcεRI to promote disease development.
The association of FcεRI with the neuropathological disorders
observed during ECM was further emphasized by the constant
increase of receptor α chain mRNA expression in the brain of
infected mice. Conventional effector cells expressing FcεRI in
mice consist of MCs and basophils. Interestingly however, our
data using MC-deﬁcient mice or antibody-mediated depletion of
basophils excluded MCs and basophils as relevant effector cells
(Porcherie et al., 2011). They also did not show beneﬁcial actions
of MCs in contrast to previous data, which reported that MCs
and MC-derived TNF-α protect against ECM (Furuta et al., 2006).
This contradictory result may have been inﬂuenced by the dif-
ferent MC-deﬁcient W/Wv mouse strain used, which makes the
mice anemic, and thus potentially compromised in controlling a
parasite infection. It was also puzzling that TNF-α was protective
in this study, although TNF-α generally enhances disease sever-
ity (Grau et al., 1987). Searching for alternative FcεRI-expressing
cell types, we identiﬁed neutrophils and eosinophils, and discov-
ered that the former had a disease enhancing capacity (Porcherie
et al., 2011). Although FcεRIα is essentially absent in neutrophils
in naive mice, we found that it becomes induced during Plasmod-
ium infection as demonstrated by the increase in expression of α
chain mRNA using RT-PCR analysis, the binding of the α chain–
speciﬁc MAR-1 antibody, and detection of membrane-bound IgE.
Attempts to characterize the biochemical nature of this receptor
on neutrophils showed that the receptor was colocalized with the
FcεRIγ subunit that could be coimmunoprecipitated with IgE.
In contrast, the FcεRIβ chain was undetectable in neutrophils
(Porcherie et al., 2011). Although expression of the receptor in the
absence of FcεRIβ has never been demonstrated before in mice
(Miller et al., 1989), in humans FcεRI is frequently expressed in
several hematopoietic cells including monocytes, eosinophils, and
neutrophils of atopic asthmatics as a trimeric FcεRIαγ2 receptor
(Saffar et al., 2007), whereas it is absent in healthy individuals. It
has therefore been postulated that FcεRI-induced inﬂammatory
signaling and the reported antiapoptotic effect of monomeric IgE
may exacerbate the pathogenetic effects of FcεRI+ neutrophils
in asthma (Saffar et al., 2007). A parallel can be made in the
present work as to the possible implication of FcεRI+ neutrophils
in malaria pathogenesis. The evidence for that was that transfer
of FcεRI+, but not FcεRI−, neutrophils conferred ECM suscep-
tibility to the otherwise resistant FcεRI-α-KO mice (Porcherie
et al., 2011). Furthermore, this sub-population was speciﬁcally
enhanced in the brain during ECM development. These results
emphasize the critical role of FcεRI+ neutrophils in the disease
expression and mortality, as the sequestration properties of this
cell population in the brain tissue occurs rapidly, within an hour
after cell transfer, in PbANKA-infected FcεRI-α-KO mice that are
otherwise CM resistant.
Several questions remain unresolved. In particular, the Plas-
modium infection-associated signals required for the induction
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FIGURE 1 | Schematic representation of the identification of the
different components of the allergic cascade that are involved in the
pathogenesis of experimental cerebral malaria. Using the
well-established murine model of cerebral malaria whereby C57BL/6 mice
were infected with PbANKA parasite strain which causes the disease and
mortality within 6–10 days, each step of the IgE-mediated allergic cascade,
including IgE, FcεRI, mast cells, basophils, histamine as one of the
mediators released upon activation of these cells, and granulocytes such
as neutrophils and eosinophils, was explored individually using either
mutant mice (IgE−/−, CD117−/−, FcεRIα−/−, HDC−/−) or antibody-based
depletion procedures (for basophils using the Ba103 mAb, for neutrophils
using the NIMP-R14 mAb, and for eosinophils anti-Siglec-F Ab). Each
component of this cascade tested gave rise to either a sensitive or
resistant phenotype with regard to cerebral malaria.
of FcεRI expression in neutrophils are unknown. However, this
property seems to be speciﬁc to the ECM-inducing PbANKA
parasite, as mice infected with non-ECM-inducing PbNK65 par-
asite or mice infected with Escherichia coli undergoing septic
peritonitis as a result of cecal ligation and puncture did not
show any expression of FcεRI in their neutrophils (Porcherie
et al., 2011). However, a precedent for the expression of FcεRI
in the absence of FcεRIβ in mice has previously been made
in lung DCs after infection with Sendai virus (Grayson et al.,
2007). It is therefore conceivable that infectious events may
enable expression of a trimeric FcεRIαγ2 receptor by masking
inherent retention signals of the α chain (Blank et al., 1991;
Hartman et al., 2008). Alternatively, they may induce expres-
sion of “β-like” molecules that support receptor expression.
Additional studies are necessary to clarify the various aspects
leading to the activation of FcεRI+ neutrophils during malaria
disease.
CONCLUSION
Undesirable inﬂammatory responses are often involved in the
pathogenesis of many diseases. Therefore, it was legitimate to ask
whether IgE-mediated allergic inﬂammatory response in atopic
individuals living in endemic areas may predispose this particu-
lar population to develop severe forms of malaria disease such as
severe anemia and CM. As discussed in this review, many promi-
nent groups have investigated this issue using essentially immuno-
epidemiological tools as well as genetic approaches. As cause-and-
effect relationship between IgE response and disease outcome is
difﬁcult to achieve, there are still questions as to whether allergic
diseases represent aggravating conditions for malaria.
Although animal models of malaria disease and infection do
not perfectly match the human situation, they are still informa-
tive in terms of exploring and understanding the basic mecha-
nisms. To this aim, we designed a comprehensive and integrated
approach where each step of the IgE-mediated allergic inﬂamma-
tory cascade has been assessed for its possible implication in the
disease pathogenesis in a well-established murine model of CM
(Figure 1).
Collectively, our ﬁndings provide a new concept on inﬂam-
matory response-driven malaria pathogenesis where neutrophils
play a central role in inducing allergic type reactions, implicated
in the development of ECM. In particular, we identiﬁed a novel
sub-population of neutrophils expressing the FcεRI, exclusively
induced during a malaria parasite infection resulting in CM.
Although the involvement of neutrophils in malaria pathology is
now established, the effector mechanisms whereby the inducible
FcεRI+ neutrophil population contributes to the disease patho-
genesis remain unresolved. Whilst it is well-established that the
inﬂammatory response plays a decisive role in malaria pathogen-
esis, the concept that neutrophils play a key role in this adds a new
piece to the pathogenic puzzle underlying malaria disease. One of
the possible implications of this seminal work in a mouse model
of CM will be to establish its relevance to the human condition.
Moreover, mutations in FcεRI have been associated with asthma
and their relevance for severe outcome of Plasmodium infections
deserves to be addressed in the future.
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